
According to Benzinga Pro, during Q3, Haemonetics (NYSE:HAE) earned $23.23 million, a 56.38% increase from the preceding quarter. Haemonetics also posted a total of $259.77 million in sales, a 8.28% increase since Q2. Haemonetics earned $14.86 million, and sales totaled $239.90 million in Q2.